Cryptocurrencies: Cryptocurrency quotes are updated in real-time.

Mit einem weltweiten Umsatz von rund 22 Milliarden US-Dollar (2019) ist es eines der größten Pharmaunternehmen der Welt. By Chris Wack Gilead Sciences Inc. and Galapagos NV said Monday that data demonstrated sustained efficacy and safety with filgotinib, a treatment for moderately to severely active ulcerative... | October 12, 2020

By using this site you agree to the There are also alternatives, such as Regeneron's (NASDAQ:REGN) REGN-COV2 antibody cocktail, which President Donald Trump took under a "compassionate use" request (the company is currently seeking EUA from the FDA) when he contracted COVID-19. Alaska Bought Up Gilead, Lilly, and Wells Fargo Stock. In April, the National Institute of Allergy and Infectious Diseases (NIAID) released the results of a study on remdesivir that showed that hospitalized patients with advanced COVID-19 who took the drug recovered 31% more quickly than others, speeding up recovery time by four days. All rights reserved.

Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Gilead Sciences, Inc. ist ein Pharmazie- und Biotechnologieunternehmen aus den Vereinigten Staaten mit Sitz in Foster City, Kalifornien.Das Unternehmen ist im S&P 500 gelistet.

Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

It will go away’: A look back at Trump’s shifting stance on face masks and on the threat of COVID-19, Medical Terms Used by Trump’s Physician, Explained, 10 Stocks to Buy as the Health-Care Revolution Races Ahead, According to Experts, Remdesivir has little effect on mortality according to WHO study - FT, Gilead Science lands WHO distinction for remdesivir, Regeneron's (REGN) Inmazeb Ebola Treatment Gets FDA Approval, Stocks Down 2nd Straight Day: Prime, Lilly, United Q3 & More, Gilead: Incredible Antivirals, Risky Drug Lineup, Biotech Stock Roundup: REGN, GILD's Coronavirus News & Other Pipeline Updates, Gilead Sciences says waiting period for Immunomedics tender offer expires, Lilly's Coronavirus Antibody Study Paused on Safety Concerns, Gilead Sciences (GILD) Stock Moves -0.09%: What You Should Know, Gilead & Galapagos Announce Positive Data on UC Candidate, Lilly's Mirikizumab Retains Efficacy in Crohn's Disease Study, 6 Unpopular Stocks That Scored Major Analyst Upgrades Ahead of Earnings, Aligos Therapeutics Proposes Terms For $150 Million IPO, AstraZeneca's Coronavirus Antibody Therapy to Enter Late Stage, Gilead Up on Positive Final Results for Coronavirus Treatment, Sarepta: Leading The Genomic Medicine Pack. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC.

And the company's CEO, Daniel O'Day, told CNBC that Gilead has "ample supply" of the drug, and that by the end of October it will have enough to supply patients around the world.

Let's look at whether its stock is a good investment during the pandemic. Das Medikament Remdesivir des US-Konzerns Gilead Sciences hat nach einer Studie der Weltgesundheitsorganisation WHO keinen substanziellen Einfluss auf die Heilung von Covid-19-Patienten. Volume: Oct 13, 2020 1:04 AM EDT. This browser is no longer supported at MarketWatch.

Subscriber Agreement & Terms of Use, Copyright 2019© FactSet Research Systems Inc. All rights reserved.

Cumulative Growth of a $10,000 Investment in Stock Advisor, Is Gilead Sciences a Good Coronavirus Stock to Buy? Have Watchlists? International stock quotes are delayed as per exchange requirements.

Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Gilead Sciences' stock is owned by a number of retail and institutional investors. In September, the Centers for Disease Control and Prevention predicted that by the third quarter of next year, enough vaccines will be available for the coronavirus that Americans should start to be able to return to their normal lives. These 2 Dividend Stocks Are Cheap Buys Today, Copyright, Trademark and Patent Information.

Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Intraday data delayed at least 15 minutes or per exchange requirements. A study released earlier this month in the New England Journal of Medicine found that hospitalized COVID-19 patients taking remdesivir recovered five days quicker, compared with median recovery times, than patients who only received a placebo. Gilead's stock has been volatile, but if you had bought it early, right after its IPO in 1992, you would have done quite well. Gilead and Merck’s Billion Dollar Bets Face Tests as Ink Dries, Dealmakers See $69 Billion of M&A in Year’s Busiest Weekend. © 2020 Cable News Network. All rights reserved.

View real-time stock prices and stock quotes for a full financial overview.

It's clear that remdesivir is effective in reducing the recovery time of patients with COVID-19, so it could be an attractive coronavirus stock to own. Rund 9.000 Mitarbeiter sind bei Gilead Sciences beschäftigt (Stand 2018).